POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
By LabMedica International staff writers Posted on 14 Mar 2024 |
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics. Traditionally, exosomes are isolated through ultrasound centrifugation, a process that requires eight hours or more, requires large sample volumes, and often harms the integrity of these delicate structures. Alternative methods also present challenges, including low purity and yield. Now, researchers have devised a diagnostic technique that employs sound waves to spin a single water droplet at speeds reaching 6,000 revolutions per minute, thereby facilitating the separation of tiny biological particles for exosome-based diagnostics.
This novel approach involves a lightweight disk atop the spinning droplet and featuring etched channels that incorporate star-shaped nanoparticles designed for the label-free identification of exosomes. This method surpasses traditional techniques in efficiency, requiring less time and smaller sample volumes, and minimizes damage to the exosomes. It represents a significant advancement from the expensive equipment currently used for exosome isolation, paving the way for point-of-care applications, including precision bioassays and cancer diagnostics.
Developed by mechanical engineers at Duke University (Durham, NC, USA), the technology utilizes a droplet of water placed within a polydimethylsiloxane ring—a silicone material frequently used in microfluidics—to confine the water’s boundaries and keeps it in place. Sound wave generators positioned on either side of the device emit surface acoustic waves that cause the droplet to spin rapidly. A disc with channels etched on its surface is placed on top of the droplet. As the droplet spins, exosomes are driven toward the ends of the channels, separating them from smaller proteins and contaminants.
To detect the presence of specific biomarkers, the researchers used a technological approach that tethers DNA probes dubbed “Inverse Molecular Sentinels” to the points of star-shaped gold nanoparticles. These tethers naturally want to curl up, but are held straight by a segment of DNA that is tailored to bind to the target microRNA being tested for. When that microRNA comes by on its exosome carrier, it sticks to and removes the DNA, allowing the tether to curl and bring the label molecule in close contact with the nanostar. When exposed to a laser, that label molecule emits a very weak Raman signal. However, the shape and composition of the nanostars amplifies the Raman signals several million-fold and make them easier to detect.
“Our technology can discriminate between cancer and control groups with 95.8% sensitivity and 100% selectivity,” said Tony Jun Huang, the William Bevan Distinguished Professor of Mechanical Engineering and Materials Science at Duke. “Its potential is enormous in fundamental biological research and the early diagnosis and health monitoring of cancers, neurodegenerative and other diseases.”
Related Links:
Duke University
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines
- Compact Immunoassay and Clinical Chemistry Analyzer Helps Low- to Mid-Volume Labs Tackle Challenges